SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-194252
Filing Date
2013-05-02
Accepted
2013-05-02 08:19:38
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d514837d10q.htm 10-Q 519248
2 EX-31.1 d514837dex311.htm EX-31.1 9154
3 EX-31.2 d514837dex312.htm EX-31.2 9335
4 EX-32.1 d514837dex321.htm EX-32.1 3488
5 EX-32.2 d514837dex322.htm EX-32.2 3838
  Complete submission text file 0001193125-13-194252.txt   3948688

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT thld-20130331.xml EX-101.INS 665488
7 XBRL TAXONOMY EXTENSION SCHEMA thld-20130331.xsd EX-101.SCH 29629
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20130331_cal.xml EX-101.CAL 45416
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thld-20130331_def.xml EX-101.DEF 101986
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20130331_lab.xml EX-101.LAB 274855
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20130331_pre.xml EX-101.PRE 199612
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 13805477
SIC: 2834 Pharmaceutical Preparations